Published in Development on February 01, 1989
PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci (2008) 5.25
Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci U S A (1993) 3.45
Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol (2003) 3.06
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol (2006) 2.34
Age-dependent fate and lineage restriction of single NG2 cells. Development (2011) 2.29
Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A (2002) 2.10
De novo generation of neuronal cells from the adult mouse brain. Proc Natl Acad Sci U S A (1992) 1.97
Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models. Nat Neurosci (2012) 1.86
Oligodendrocytes: biology and pathology. Acta Neuropathol (2009) 1.81
The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J (2000) 1.79
Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J (1997) 1.77
NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat (2005) 1.68
NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron (2011) 1.67
Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia (2007) 1.62
NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neurosci (2010) 1.52
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain (2009) 1.49
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci (2010) 1.46
Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. J Cell Biol (2000) 1.40
Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J Cell Biol (1992) 1.29
Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells (2007) 1.27
Cell size control and a cell-intrinsic maturation program in proliferating oligodendrocyte precursor cells. J Cell Biol (1997) 1.25
Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci U S A (2010) 1.24
Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS One (2008) 1.20
In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells. J Cell Biol (1992) 1.12
Oligodendrocyte fate after spinal cord injury. Neurotherapeutics (2011) 1.09
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas. Lab Invest (2008) 1.06
Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc Natl Acad Sci U S A (1989) 1.05
NG2 cells (polydendrocytes): listeners to the neural network with diverse properties. Glia (2014) 1.04
The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn (2012) 1.02
Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J Cereb Blood Flow Metab (2009) 1.02
HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology. Glia (2009) 1.02
Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J Neurosci (2011) 1.01
Developmental stage of oligodendrocytes determines their response to activated microglia in vitro. J Neuroinflammation (2007) 0.98
In situ dividing and phagocytosing retinal microglia express nestin, vimentin, and NG2 in vivo. PLoS One (2011) 0.97
Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1). EMBO J (2002) 0.97
Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc Natl Acad Sci U S A (1989) 0.96
Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Proc Natl Acad Sci U S A (2014) 0.95
Isolation of cortical mouse oligodendrocyte precursor cells. J Neurosci Methods (2012) 0.93
nkx2.2a promotes specification and differentiation of a myelinating subset of oligodendrocyte lineage cells in zebrafish. Neuron Glia Biol (2008) 0.92
Glial lineages and myelination in the central nervous system. J Anat (1997) 0.92
CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo. Exp Neurol (2006) 0.91
Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system. J Cell Biol (2011) 0.91
Limiting and repairing the damage in multiple sclerosis. J Neurol Neurosurg Psychiatry (1991) 0.90
In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol (1989) 0.90
Myelin repair strategies: a cellular view. Curr Opin Neurol (2008) 0.89
Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J Neurosci (2012) 0.89
Cell therapy for multiple sclerosis. Neurotherapeutics (2011) 0.89
Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-γ. J Neurosci (2011) 0.89
Oligodendrogenesis in the normal and pathological central nervous system. Front Neurosci (2014) 0.87
Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury. Neurotherapeutics (2011) 0.86
Neonatal and adult O4(+) oligodendrocyte lineage cells display different growth factor responses and different gene expression patterns. J Neurosci Res (2009) 0.86
Analysis of FGF-dependent and FGF-independent pathways in otic placode induction. PLoS One (2013) 0.85
Cell of origin for malignant gliomas and its implication in therapeutic development. Cold Spring Harb Perspect Biol (2015) 0.85
Stem cell therapy independent of stemness. World J Stem Cells (2012) 0.85
Regulation of immunoreactive GAP-43 expression in rat cortical macroglia is cell type specific. J Cell Biol (1990) 0.84
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model. J Biomater Tissue Eng (2012) 0.82
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update. Biomed Res Int (2015) 0.82
How to make an oligodendrocyte. Development (2015) 0.81
In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J Cell Biol (1990) 0.80
Precursor cell transitions in oligodendrocyte development. J Cell Biol (2000) 0.79
Epigenetics in NG2 glia cells. Brain Res (2015) 0.79
The oligodendroglial precursor cell line Oli-neu represents a cell culture system to examine functional expression of the mouse gap junction gene connexin29 (Cx29). Front Pharmacol (2013) 0.78
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration. Biophys J (2014) 0.78
Differential requirement of cyclin-dependent kinase 2 for oligodendrocyte progenitor cell proliferation and differentiation. Cell Div (2012) 0.77
Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke. Brain Res (2015) 0.77
Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease? J Neurosci Res (2016) 0.76
Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation. J Neurosci (2016) 0.76
Efficient Remyelination Requires DNA Methylation. eNeuro (2017) 0.75
Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice. BMC Complement Altern Med (2017) 0.75
Growth factors: potential therapeutic applications in neurology. J Neurol Neurosurg Psychiatry (1994) 0.75
Subependymal Zone-Derived Oligodendroblasts Respond to Focal Demyelination but Fail to Generate Myelin in Young and Aged Mice. Stem Cell Reports (2017) 0.75
Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination. J Neurosci (2017) 0.75
Brain repair: lessons from developmental biology. J Neurol (1994) 0.75
Crystal structure of a Src-homology 3 (SH3) domain. Nature (1992) 13.88
A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (1983) 6.52
Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci U S A (1982) 3.21
Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci (1993) 3.07
Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci U S A (2000) 2.99
LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell (1996) 2.44
Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci (1983) 2.18
Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem (1992) 2.05
Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature (1993) 2.00
Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A (1990) 1.89
A tripotential glial precursor cell is present in the developing spinal cord. Proc Natl Acad Sci U S A (1998) 1.87
Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J (1988) 1.80
Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ (1996) 1.74
Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms. Mol Genet Metab (2008) 1.73
Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J (1984) 1.69
Glial cells express N-CAM/D2-CAM-like polypeptides in vitro. Nature (1985) 1.66
Glia are a unique substrate for the in vitro growth of central nervous system neurons. J Neurosci (1984) 1.63
Evidence for migration of oligodendrocyte--type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature (1987) 1.62
N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci U S A (1994) 1.60
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother (2010) 1.56
Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development (1994) 1.54
Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess (Full Rep) (2013) 1.49
Quantitative insight into proliferation and differentiation of oligodendrocyte type 2 astrocyte progenitor cells in vitro. Proc Natl Acad Sci U S A (1998) 1.40
Profile of prostatic-specific antigen in prostatic carcinomas. Mod Pathol (1993) 1.39
Estimation problems associated with stochastic modeling of proliferation and differentiation of O-2A progenitor cells in vitro. Math Biosci (2000) 1.36
Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev Biol (1996) 1.33
Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J Cell Biol (1992) 1.29
Efficacy of microbial identification system for epidemiologic typing of coagulase-negative staphylococci. J Clin Microbiol (1994) 1.26
A stochastic model of brain cell differentiation in tissue culture. J Math Biol (1998) 1.20
Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation (1996) 1.20
An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mol Genet (2000) 1.13
In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells. J Cell Biol (1992) 1.12
Limk1 is predominantly expressed in neural tissues and phosphorylates serine, threonine and tyrosine residues in vitro. Oncogene (1995) 1.10
Neuropeptides modulate the beta-adrenergic response of purified astrocytes in vitro. Nature (1983) 1.09
Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc Natl Acad Sci U S A (1989) 1.05
Saddlepoint approximations to the moments of multitype age-dependent branching processes, with applications. Biometrics (2009) 1.05
Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer. J Urol (1993) 1.04
Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology (1995) 1.03
A stochastic model of temporally regulated generation of oligodendrocytes in cell culture. Math Biosci (1999) 1.03
An alternative stochastic model of generation of oligodendrocytes in cell culture. J Math Biol (2001) 1.01
Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells. Glia (2001) 1.01
Toxic material from the tentacles of the cubomedusan Chironex fleckeri. Toxicon (1971) 1.00
Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed (1995) 0.99
A random walk model of oligodendrocyte generation in vitro and associated estimation problems. Math Biosci (1999) 0.99
Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res (2000) 0.93
Ultrasonically controlled release of ciprofloxacin from self-assembled coatings on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonas aeruginosa biofilm prevention. Antimicrob Agents Chemother (2005) 0.92
Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division. Dev Biol (1994) 0.92
Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells. Glia (1991) 0.91
Coexistence of perinatal and adult forms of a glial progenitor cell during development of the rat optic nerve. Development (1990) 0.91
The pathogenesis of demyelinating disease: insights from cell biology. Trends Neurosci (1991) 0.90
Cellular and humoral immunity: a distinction in antigenic recognition. Nat New Biol (1972) 0.90
Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter. Int J Radiat Oncol Biol Phys (1992) 0.90
Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function. Biochem Soc Trans (2003) 0.90
Purification of olfactory nerve ensheathing cells from the olfactory bulb. Dev Biol (1993) 0.89
The effects of the neuN and neuT genes on differentiation and transformation of mammary epithelial cells. J Cell Sci (1994) 0.87
Glial cell lineages in the rat optic nerve. Cold Spring Harb Symp Quant Biol (1983) 0.87
The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes. Glia (1993) 0.86
Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. Eur Heart J (1998) 0.84
Single cell analysis of the expression of a nuclear protein, SCIP, by fluorescent immunohistochemistry visualized with confocal microscopy. Histochem J (1993) 0.83
Healthcare-associated infection and the patient experience: a qualitative study using patient interviews. J Hosp Infect (2009) 0.83
Tension-free vaginal tape and percutaneous vaginal tape sling procedures. Tech Urol (2001) 0.82
The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens. Eur J Immunol (1988) 0.82
The characterization of astrocyte cell lines that display properties of glial scar tissue. Dev Biol (1993) 0.81
Oligodendrocyte precursor cells in chronic multiple sclerosis lesions. Mult Scler (1997) 0.81
Long-term follow-up of intraocular lens implants: the first 127 compared with the latest 100 of the same style in a span of 9 years. Br J Ophthalmol (1984) 0.81
Further evidence on secondary task interference in tracking. J Exp Psychol (1967) 0.80
Sequential probabilities and the performance of serial tasks. J Exp Psychol (1968) 0.80
In vitro studies on the comparative sensitivities of cells of the central nervous system to diphtheria toxin. J Neurol Sci (1985) 0.80
Operant conditioning of vasoconstriction. J Exp Psychol (1968) 0.79
Origin, growth factor responses, and ultrastructural characteristics of an adult-specific glial progenitor cell. Ann N Y Acad Sci (1991) 0.79
Assignment of the human and mouse LIM-kinase genes (LIMK1; Limk1) to chromosome bands 7q11.23 and 5G1, respectively, by in situ hybridization. Cytogenet Cell Genet (1996) 0.79
The growth of olfactory neurons in short-term cultures of rat olfactory epithelium. Neurosci Lett (1984) 0.78
A prospective study of the role of lipoprotein(a) in the pathogenesis of unstable angina. Eur Heart J (1997) 0.78
Orofacial exercises for babies with breastfeeding problems? Breastfeed Rev (1999) 0.78
Cyclin-dependent kinase inhibition by new C-2 alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complex. J Med Chem (2000) 0.78
Genetic aberrations in glioblastoma multiforme: translocation of chromosome 10 in an O-2A-like cell line. Br J Cancer (1999) 0.78
Are hypothyroidism and iron deficiency precursor cell diseases? Dev Neurosci (2001) 0.78
Alleletyping of an oligodendrocyte-type-2 astrocyte lineage derive from a human glioblastoma multiforme. J Neurooncol (1998) 0.77
Eradication of methicillin-resistant Staphylococcus aureus from the lower respiratory tract of patients with cystic fibrosis. Can J Infect Dis (1995) 0.77
Interpolated activity and response mechanisms in motor short-term memory. J Exp Psychol (1972) 0.77
G7063-2, a new nitrogen-containing antibiotic of the epoxydon group, isolated from the fermentation broth of a species of Streptomyces. J Antibiot (Tokyo) (1977) 0.76
The differentiation of glial cell progenitor populations following transplantation into non-repairing central nervous system glial lesions in adult animals. J Neuroimmunol (1992) 0.76
Metabolic studies of human primitive neuroectodermal tumour cells by proton nuclear magnetic resonance spectroscopy. Br J Cancer (1997) 0.76
Blastocystis hominis infection in humans. Rev Infect Dis (1989) 0.76
An electrostatic mechanism of muscular contraction. Int J Cardiol (1989) 0.75
Studies on the enhancement of the reactivity of the (Cys-25)-S-/(His159)-Im+H ion-pair of papain by deprotonation across pKa 4. Biochem Soc Trans (1996) 0.75
Contributions of hippocampal cellular damage and NMDA receptor dysfunction to behavioral markers of schizophrenia. Int J Neurosci (2001) 0.75
Searching for traffic signals while engaged in compensatory tracking. Hum Factors (1980) 0.75
Latex agglutination test to identify coagulase, clumping factor and protein A produced by staphylococci. Clin Invest Med (1983) 0.75
[Physical approach by means of baths]. Soins Psychiatr (2000) 0.75
Motor performance on temporal tasks as a function of sequence length and coherence. J Exp Psychol (1968) 0.75
Canadian physicians should be encouraged to volunteer for overseas relief work, MDs say. CMAJ (1994) 0.75
Respiratory sensations in patients with cervical cord transection. Paraplegia (1971) 0.75
The quantification of synthetic corticosteroids using isotope dilution gas chromatography negative chemical ionization mass spectrometry. Biomed Environ Mass Spectrom (1988) 0.75
G2201-C, a new cyclopentenedione antibiotic, isolated from the fermentation broth of Streptomyces cattleya. J Antibiot (Tokyo) (1978) 0.75
Effects of the quality of the P2-S2 hydrophobic contacts on the catalytic activities of papain, caricain and ficin and their generation by electrostatic switches. Biochem Soc Trans (1997) 0.75
Adenocarcinoma of the anterior urethra in the male. Kans Med (1997) 0.75
[Procedure to follow in the presence of facial paralysis]. Bord Med (1971) 0.75